Top
US_Flag An official website of the United States government Here's how you know
GOV

The .gov means it's official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

LOCK

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

 
U.S. Food & Drug Administration
Continuing Education and Accreditation
Division of Learning and Organizational Development
Center for Drug Evaluation and Research

Cannabis and Cannabis-Derived Products – For Healthcare Practitioners

Enroll
Step Status
Educational Content ✘
Posttest ✘
Evaluation ✘
Starts On: Wed, 5/10/23: 12:00 AM EDT
Ends On: Sun, 5/10/26: 12:00 AM EDT
Type: Enduring Material
Credits: 1
Description: This webinar will provide a general understanding of the Cannabis sativa L. plant and how products are generally produced utilizing cannabis raw materials. The presentation will explain why manufacturing controls surrounding cannabis and cannabis-derived products are an integral part of protecting the public health. Will provide attendees with greater knowledge of the many products available on the marketplace, a discussion on potential benefits and risks, ways to report adverse events associated with these products to FDA, as well as suggestions on how to create a safe space to discuss patient use of these products.
Objectives:
  • Identify cannabis and cannabis-derived products on the market that are FDA approved.
  • Describe how products are manufactured and the critical quality controls for cannabis botanical raw materials and products.
  • Discuss ways to address patients' use of cannabis and cannabis-derived products.
  • Explain the potential benefits and risks that should be conveyed to patients.
Additional Information: Review the Activity Announcement for additional details: Announcement Form

Additional Resources: SLIDES